Conformation and bioactivity. Design and discovery of novel antihypertensive drugs.
D015059:1-Sarcosine-8-Isoleucine Angiotensin II / Q000031:analogs & derivatives / Q000737:chemistry; D000804:Angiotensin II / Q000031:analogs & derivatives* / Q000737:chemistry / Q000494:pharmacology; D047228:Angiotensin II Type 1 Receptor Blockers; D000959:Antihypertensive Agents / Q000138:chemical synthesis / Q000737:chemistry* / Q000494:pharmacology; D015195:Drug Design; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D019808:Losartan / Q000031:analogs & derivatives / Q000737:chemistry; D009682:Magnetic Resonance Spectroscopy; D008968:Molecular Conformation; D018716:Molecular Mimicry; D010455:Peptides / Q000737:chemistry / Q000494:pharmacology; D013329:Structure-Activity Relationship
D047228:Angiotensin II Type 1 Receptor Blockers; D000959:Antihypertensive Agents; D010455:Peptides; D000804:Angiotensin II; C040420:angiotensin II, Sar(1)-Me-Tyr(4)-; D015059:1-Sarcosine-8-Isoleucine Angiotensin II; D019808:Losartan